Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Bachy

Showing results (21-30 of 176) with videos related to

Pageof 18
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Hepatitis C virus infection and lymphomaEmmanuel Bachy, Caroline Besson, Felipe Suarez, et al.
Blood Research|April 9, 2019
Breast implant-associated anaplastic large cell lymphomaLucile Baseggio, Alexandra Travers-Glehen, Emmanuel Bachy, et al.
British Journal of Haematology|February 1, 2011
Quantitative and functional analyses of CD4(+) CD25(+) FoxP3(+) regulatory T cells in chronic phase chronic myeloid leukaemia patients at diagnosis and on imatinib mesylateEmmanuel Bachy, Janine Bernaud, Pascal Roy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2022
B-cell malignancies and COVID-19: a narrative reviewDavid Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Expert Review of Anti-Infective Therapy|July 15, 2022
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to loseDavid Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Bulletin Du Cancer|January 29, 2019
Gilles Salles, Pierre Sesques, Emmanuelle Ferrant, et al.
Advances in Therapy|May 27, 2021
Phase III Clinical Trials in First-Line Follicular Lymphoma: A Review of Their Design and InterpretationEmmanuel Bachy, Kaspar Rufibach, Joana Parreira, et al.
Bulletin Du Cancer|December 18, 2021
CAR-T cell: Toxicities issues: Mechanisms and clinical managementFlorent Wallet, Pierre Sesques, Perrine Devic, et al.
Advances in Therapy|September 24, 2024
A Cost-Effectiveness Analysis of Axicabtagene Ciloleucel versus Tisagenlecleucel in the Treatment of Diffuse Large B-cell Lymphoma Based on a Real-World French RegistryMarkqayne Ray, Jean-Gabriel Castaigne, Alexandra Zang, et al.
Leukemia & Lymphoma|August 13, 2024
CAR T-cells in very elderly (≥80 years) lymphoma patients: a DESCAR-T analysisSimon Menez, Estelle Bourbon, Romain Gounot, et al.
Pageof 18

Showing results (21-30 of 176) with videos related to

Sort By:
Pageof 18
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Hepatitis C virus infection and lymphomaEmmanuel Bachy, Caroline Besson, Felipe Suarez, et al.
Blood Research|April 9, 2019
Breast implant-associated anaplastic large cell lymphomaLucile Baseggio, Alexandra Travers-Glehen, Emmanuel Bachy, et al.
British Journal of Haematology|February 1, 2011
Quantitative and functional analyses of CD4(+) CD25(+) FoxP3(+) regulatory T cells in chronic phase chronic myeloid leukaemia patients at diagnosis and on imatinib mesylateEmmanuel Bachy, Janine Bernaud, Pascal Roy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2022
B-cell malignancies and COVID-19: a narrative reviewDavid Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Expert Review of Anti-Infective Therapy|July 15, 2022
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to loseDavid Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Bulletin Du Cancer|January 29, 2019
Gilles Salles, Pierre Sesques, Emmanuelle Ferrant, et al.
Advances in Therapy|May 27, 2021
Phase III Clinical Trials in First-Line Follicular Lymphoma: A Review of Their Design and InterpretationEmmanuel Bachy, Kaspar Rufibach, Joana Parreira, et al.
Bulletin Du Cancer|December 18, 2021
CAR-T cell: Toxicities issues: Mechanisms and clinical managementFlorent Wallet, Pierre Sesques, Perrine Devic, et al.
Advances in Therapy|September 24, 2024
A Cost-Effectiveness Analysis of Axicabtagene Ciloleucel versus Tisagenlecleucel in the Treatment of Diffuse Large B-cell Lymphoma Based on a Real-World French RegistryMarkqayne Ray, Jean-Gabriel Castaigne, Alexandra Zang, et al.
Leukemia & Lymphoma|August 13, 2024
CAR T-cells in very elderly (≥80 years) lymphoma patients: a DESCAR-T analysisSimon Menez, Estelle Bourbon, Romain Gounot, et al.
Pageof 18